Inefficacy of N-methyl-D-aspartate receptor complex antagonists on behavioral and histologic consequences of global cerebral ischemia in rats;Inefficacite des antagonistes du complexe receptorial N-methyl-D-aspartate a l'egard des consequences comportementales et histologiques d'une ischemie cerebrale globale chez le rat

Annales Pharmaceutiques Francaises

Volumn 58, Issue 4, 2000, Pages 266-270

  Allaf, R ^a,b   Vistelle, R ^b   Boulu, R G ^a  

^a Faculte de Pharmacie   (France)

^b UFR de Pharmacie   (France)

Author keywords

Antagonists; Elevated plus maze; Global cerebral ischemia; Glutamic acid; N methyl D aspartate; Neurological deficit; Neuronal lesions; Rat

Indexed keywords

DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; DIZOCILPINE MALEATE; GLUTAMATE RECEPTOR; KYNURENIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; NEUROPROTECTION; NONHUMAN; RAT; ANIMAL; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TRANSIENT ISCHEMIC ATTACK; WISTAR RAT;

ANIMALS; BRAIN; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; ISCHEMIC ATTACK, TRANSIENT; KYNURENIC ACID; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 0034222012     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pulsinelli WA, Brierley JB, Plum F. Ann Neurol 1982; 11. 491-8.
2. Capdeville C, LePeillet E, Plotkine M, Boulu RG. Varying duration of global cerebral ischemia in rats: influence on behavioral consequences. In: Krieglstein eds. Pharmacology of Cerebral Ischemia. Elsevier, 1986: 304-8.
3. Petito CK, Feldmann E, Pulsinelli WA, Plum F. Neurology 1987; 37: 1281-6.
4. Olney JW. Neurotoxicity of excitatory aminoacids. In: Me Geer EG, Olney JW, Me Geer PL, eds. Kainic Acid as a Tool in Neurobiology. New York: Raven Press, 1987: 37-70.
5. Choi DW, Rothman SM. Ann Rev Neurosci 1990; 13. 171-82.
6. Benveniste H, Dreger J, Schousboe A, Diemer NH. J Neurochem 1984; 43: 1369-74.
7. Boulu RG. Act Pharm Biol Clin 1994; 7: 161-74.
8. Gill R, Brazell C, Woodruff GN, Kemp JA. Br J Pharmacol 1991; 103: 2030-6.
9. Margaill I, Parmentier S, Callebert J, Allix M, Boulu RG, Plotkine M. J Cereb Blood Flow Metab 1996; 16: 107-13.
10. Buchan AM, Li H, Pulsinelli WA. J Neurosci 1991; 11: 1049-56.
11. Saji M, Hamasaki M, Ohno K. Yonago Acta Medica 1995; 38 229-36.
12. Gill R. Cerebrevasc Brain Metabol Rev 1994; 6. 225-56.
13. Pulsinelli WA, Brierley JB. Stroke 1979; 10: 267-72.
14. Wong EH, Kemp JA, Priestley T, Knignt AR, Woodruff G, Iversen LL. Proc Natl Acad Sci USA 1986; 83: 7104-8.
15. Kemp JA, Grimwood S, Foster AC. Br J Pharmacol 1987; 91 Suppl: 314.
16. Lekieffre D, Ghribi O, Callebert J, Plotkine M, Boulu RG. Circ Métabol Cerveau 1992; 9: 31-46.
17. Marvizon JC, Lewin AH, Skolnick P. J Neurochem 1989; 52: 992-4.
18. Fossom LH, Von Lubitz DK, Lin RC, Skolnick P. Neurol Res 1995; 17: 265-9.
19. Lekieffre D. Thèse de Doctorat de l'Université Paris VI, 1991.
20. Pellow S, File SE. Pharmacol Biochem Behav 1986; 24: 525-9.
21. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press eds. Sydney, Australia 1982.
22. Birch PJ, Grossman CJ, Hayes AG, Eur J Pharmacol 1988; 154: 85-7.